Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2293 to 2302 of 2302 entries
Sorted by: Best Match Show Resources per page
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance.

The Lancet regional health. Europe

Pritchard E, Jones J, Vihta KD, Stoesser N, Matthews PPC, Eyre DW, House T, Bell JI, Newton PJN, Farrar J, Crook PD, Hopkins S, Cook D, Rourke E, Studley R, Diamond PI, Peto PT, Pouwels KB, Walker PAS.
PMID: 34927119
Lancet Reg Health Eur. 2022 Feb;13:100282. doi: 10.1016/j.lanepe.2021.100282. Epub 2021 Dec 12.

BACKGROUND: The COVID-19 pandemic is rapidly evolving, with emerging variants and fluctuating control policies. Real-time population screening and identification of groups in whom positivity is highest could help monitor spread and inform public health messaging and strategy.METHODS: To develop...

Cite
Pritchard E, Jones J, Vihta KD, et al. Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance. Lancet Reg Health Eur. 2021;13:100282doi: 10.1016/j.lanepe.2021.100282.
Pritchard, E., Jones, J., Vihta, K. D., Stoesser, N., Matthews, P. P. C., Eyre, D. W., House, T., Bell, J. I., Newton, P. J. N., Farrar, J., Crook, P. D., Hopkins, S., Cook, D., Rourke, E., Studley, R., Diamond, P. I., Peto, P. T., Pouwels, K. B., Walker, P. A. S. (2022). Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance. The Lancet regional health. Europe, 13100282. https://doi.org/10.1016/j.lanepe.2021.100282
Pritchard, Emma, et al. "Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance." The Lancet regional health. Europe vol. 13 (2022): 100282. doi: https://doi.org/10.1016/j.lanepe.2021.100282
Pritchard E, Jones J, Vihta KD, Stoesser N, Matthews PPC, Eyre DW, House T, Bell JI, Newton PJN, Farrar J, Crook PD, Hopkins S, Cook D, Rourke E, Studley R, Diamond PI, Peto PT, Pouwels KB, Walker PAS. Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance. Lancet Reg Health Eur. 2022 Feb;13:100282. doi: 10.1016/j.lanepe.2021.100282. Epub 2021 Dec 12. PMID: 34927119; PMCID: PMC8665900.
Copy Download .nbib Format: NLM
Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces.

The Science of the total environment

Rozwalak P, Podkowa P, Buda J, Niedzielski P, Kawecki S, Ambrosini R, Azzoni RS, Baccolo G, Ceballos JL, Cook J, Di Mauro B, Ficetola GF, Franzetti A, Ignatiuk D, Klimaszyk P, Łokas E, Ono M, Parnikoza I, Pietryka M, Pittino F, Poniecka E, Porazinska DL, Richter D, Schmidt SK, Sommers P, Souza-Kasprzyk J, Stibal M, Szczuciński W, Uetake J, Wejnerowski Ł, Yde JC, Takeuchi N, Zawierucha K.
PMID: 34627905
Sci Total Environ. 2022 Feb 10;807:150874. doi: 10.1016/j.scitotenv.2021.150874. Epub 2021 Oct 08.

Cryoconite is a mixture of mineral and organic material covering glacial ice, playing important roles in biogeochemical cycles and lowering the albedo of a glacier surface. Understanding the differences in structure of cryoconite across the globe can be important...

Cite
Rozwalak P, Podkowa P, Buda J, et al. Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces. Sci Total Environ. 2021;807:150874doi: 10.1016/j.scitotenv.2021.150874.
Rozwalak, P., Podkowa, P., Buda, J., Niedzielski, P., Kawecki, S., Ambrosini, R., Azzoni, R. S., Baccolo, G., Ceballos, J. L., Cook, J., Di Mauro, B., Ficetola, G. F., Franzetti, A., Ignatiuk, D., Klimaszyk, P., Łokas, E., Ono, M., Parnikoza, I., Pietryka, M., Pittino, F., Poniecka, E., Porazinska, D. L., Richter, D., Schmidt, S. K., Sommers, P., Souza-Kasprzyk, J., Stibal, M., Szczuciński, W., Uetake, J., Wejnerowski, �. �., Yde, J. C., Takeuchi, N., & Zawierucha, K. (2022). Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces. The Science of the total environment, 807150874. https://doi.org/10.1016/j.scitotenv.2021.150874
Rozwalak, Piotr, et al. "Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces." The Science of the total environment vol. 807 (2022): 150874. doi: https://doi.org/10.1016/j.scitotenv.2021.150874
Rozwalak P, Podkowa P, Buda J, Niedzielski P, Kawecki S, Ambrosini R, Azzoni RS, Baccolo G, Ceballos JL, Cook J, Di Mauro B, Ficetola GF, Franzetti A, Ignatiuk D, Klimaszyk P, Łokas E, Ono M, Parnikoza I, Pietryka M, Pittino F, Poniecka E, Porazinska DL, Richter D, Schmidt SK, Sommers P, Souza-Kasprzyk J, Stibal M, Szczuciński W, Uetake J, Wejnerowski Ł, Yde JC, Takeuchi N, Zawierucha K. Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces. Sci Total Environ. 2022 Feb 10;807:150874. doi: 10.1016/j.scitotenv.2021.150874. Epub 2021 Oct 08. PMID: 34627905.
Copy Download .nbib Format: NLM
Human conjunctival mast cell responses in vitro to various secretagogues.

Ocular immunology and inflammation

Miller S, Cook E, Graziano F, Spellman J, Yanni J.
PMID: 22827332
Ocul Immunol Inflamm. 1996;4(1):39-50. doi: 10.3109/09273949609069126.

Human conjunctiva was enzymatically digested into monodispersed cell preparations using collagenase and hyaluronidase. The preparations were enriched for mast cells using Percoll gradient centrifugation prior to challenge with various secretagogues. Mast cell percentage (9.7 ± 2.9%) and viability (96...

Cite
Miller S, Cook E, Graziano F, et al. Human conjunctival mast cell responses in vitro to various secretagogues. Ocul Immunol Inflamm. 1996;4(1):39-50doi: 10.3109/09273949609069126.
Miller, S., Cook, E., Graziano, F., Spellman, J., & Yanni, J. (1996). Human conjunctival mast cell responses in vitro to various secretagogues. Ocular immunology and inflammation, 4(1), 39-50. https://doi.org/10.3109/09273949609069126
Miller, S, et al. "Human conjunctival mast cell responses in vitro to various secretagogues." Ocular immunology and inflammation vol. 4,1 (1996): 39-50. doi: https://doi.org/10.3109/09273949609069126
Miller S, Cook E, Graziano F, Spellman J, Yanni J. Human conjunctival mast cell responses in vitro to various secretagogues. Ocul Immunol Inflamm. 1996;4(1):39-50. doi: 10.3109/09273949609069126. PMID: 22827332.
Copy Download .nbib Format: NLM
Curium(iii) radiation-induced reaction kinetics in aqueous media.

Dalton transactions (Cambridge, England : 2003)

Horne GP, Grimes TS, Zalupski PR, Meeker DS, Albrecht-Schönzart TE, Cook AR, Mezyk SP.
PMID: 34296716
Dalton Trans. 2021 Aug 21;50(31):10853-10859. doi: 10.1039/d1dt01268a. Epub 2021 Jul 23.

Insight into the effects of radiolytic processes on the actinides is critical for advancing our understanding of their solution chemistry because the behaviour of these elements cannot be easily separated from the influence of their inherent radiation field. However,...

Cite
Horne GP, Grimes TS, Zalupski PR, et al. Curium(iii) radiation-induced reaction kinetics in aqueous media. Dalton Trans. 2021;50(31):10853-10859doi: 10.1039/d1dt01268a.
Horne, G. P., Grimes, T. S., Zalupski, P. R., Meeker, D. S., Albrecht-Schönzart, T. E., Cook, A. R., & Mezyk, S. P. (2021). Curium(iii) radiation-induced reaction kinetics in aqueous media. Dalton transactions (Cambridge, England : 2003), 50(31), 10853-10859. https://doi.org/10.1039/d1dt01268a
Horne, Gregory P, et al. "Curium(iii) radiation-induced reaction kinetics in aqueous media." Dalton transactions (Cambridge, England : 2003) vol. 50,31 (2021): 10853-10859. doi: https://doi.org/10.1039/d1dt01268a
Horne GP, Grimes TS, Zalupski PR, Meeker DS, Albrecht-Schönzart TE, Cook AR, Mezyk SP. Curium(iii) radiation-induced reaction kinetics in aqueous media. Dalton Trans. 2021 Aug 21;50(31):10853-10859. doi: 10.1039/d1dt01268a. Epub 2021 Jul 23. PMID: 34296716.
Copy Download .nbib Format: NLM
Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK.

The Journal of hospital infection

Manoukian S, Stewart S, Graves N, Mason H, Robertson C, Kennedy S, Pan J, Kavanagh K, Haahr L, Adil M, Dancer SJ, Cook B, Reilly J.
PMID: 34301395
J Hosp Infect. 2021 Aug;114:43-50. doi: 10.1016/j.jhin.2020.12.027.

BACKGROUND: Healthcare-associated infection (HAI) is associated with increased morbidity and mortality resulting in excess costs.AIM: To investigate the impact of all types of HAI on the inpatient cost of HAI using different approaches.METHODS: The incidence, types of HAI, and...

Cite
Manoukian S, Stewart S, Graves N, et al. Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK. J Hosp Infect. 2021;114:43-50doi: 10.1016/j.jhin.2020.12.027.
Manoukian, S., Stewart, S., Graves, N., Mason, H., Robertson, C., Kennedy, S., Pan, J., Kavanagh, K., Haahr, L., Adil, M., Dancer, S. J., Cook, B., & Reilly, J. (2021). Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK. The Journal of hospital infection, 11443-50. https://doi.org/10.1016/j.jhin.2020.12.027
Manoukian, S, et al. "Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK." The Journal of hospital infection vol. 114 (2021): 43-50. doi: https://doi.org/10.1016/j.jhin.2020.12.027
Manoukian S, Stewart S, Graves N, Mason H, Robertson C, Kennedy S, Pan J, Kavanagh K, Haahr L, Adil M, Dancer SJ, Cook B, Reilly J. Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK. J Hosp Infect. 2021 Aug;114:43-50. doi: 10.1016/j.jhin.2020.12.027. PMID: 34301395.
Copy Download .nbib Format: NLM
Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.

Cancers

Zhang D, Shah NJ, Cook M, Blackburn M, Serzan MT, Advani S, Potosky AL, Atkins MB, Braithwaite D.
PMID: 34885219
Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236109.

Evidence regarding the association between body mass index (BMI) and immune-related adverse events (irAEs) among cancer patients receiving immune checkpoint inhibitors (ICIs) is limited. Here, we use cross-sectional hospital-based data to explore their relationship. Pre-treatment BMI was treated as...

Cite
Zhang D, Shah NJ, Cook M, et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13236109.
Zhang, D., Shah, N. J., Cook, M., Blackburn, M., Serzan, M. T., Advani, S., Potosky, A. L., Atkins, M. B., & Braithwaite, D. (2021). Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers, 13(23), . https://doi.org/10.3390/cancers13236109
Zhang, Dongyu, et al. "Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13236109
Zhang D, Shah NJ, Cook M, Blackburn M, Serzan MT, Advani S, Potosky AL, Atkins MB, Braithwaite D. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236109. PMID: 34885219; PMCID: PMC8657283.
Copy Download .nbib Format: NLM
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.

The International journal on drug policy

Farrell M, Shahbazi J, Byrne M, Grebely J, Lintzeris N, Chambers M, Larance B, Ali R, Nielsen S, Dunlop A, Dore GJ, McDonough M, Montebello M, Nicholas T, Weiss R, Rodgers C, Cook J, Degenhardt L.
PMID: 34736130
Int J Drug Policy. 2021 Nov 01;100:103492. doi: 10.1016/j.drugpo.2021.103492. Epub 2021 Nov 01.

BACKGROUND: Opioid agonist treatment (OAT) is an effective intervention for opioid dependence. Extended-release buprenorphine injections (BUP-XR) may have additional potential benefits over sublingual buprenorphine. This single-arm trial evaluated outcomes among people receiving 48 weeks of BUP-XR in diverse community...

Cite
Farrell M, Shahbazi J, Byrne M, et al. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. Int J Drug Policy. 2021;100:103492doi: 10.1016/j.drugpo.2021.103492.
Farrell, M., Shahbazi, J., Byrne, M., Grebely, J., Lintzeris, N., Chambers, M., Larance, B., Ali, R., Nielsen, S., Dunlop, A., Dore, G. J., McDonough, M., Montebello, M., Nicholas, T., Weiss, R., Rodgers, C., Cook, J., Degenhardt, L. (2021). Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. The International journal on drug policy, 100103492. https://doi.org/10.1016/j.drugpo.2021.103492
Farrell, Michael, et al. "Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence." The International journal on drug policy vol. 100 (2021): 103492. doi: https://doi.org/10.1016/j.drugpo.2021.103492
Farrell M, Shahbazi J, Byrne M, Grebely J, Lintzeris N, Chambers M, Larance B, Ali R, Nielsen S, Dunlop A, Dore GJ, McDonough M, Montebello M, Nicholas T, Weiss R, Rodgers C, Cook J, Degenhardt L. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. Int J Drug Policy. 2021 Nov 01;100:103492. doi: 10.1016/j.drugpo.2021.103492. Epub 2021 Nov 01. PMID: 34736130.
Copy Download .nbib Format: NLM
Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy.

Journal of the Endocrine Society

Cook K, Adamski K, Gomes A, Tuttle E, Kalden H, Cochran E, Brown RJ.
PMID: 33817539
J Endocr Soc. 2021 Feb 16;5(4):bvab019. doi: 10.1210/jendso/bvab019. eCollection 2021 Apr 01.

Generalized and partial lipodystrophy are rare and complex diseases with progressive clinical and humanistic burdens stemming from selective absence of subcutaneous adipose tissue, which causes reduced energy storage capacity and a deficiency of adipokines such as leptin. Treatment options...

Cite
Cook K, Adamski K, Gomes A, et al. Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy. J Endocr Soc. 2021;5(4):bvab019doi: 10.1210/jendso/bvab019.
Cook, K., Adamski, K., Gomes, A., Tuttle, E., Kalden, H., Cochran, E., & Brown, R. J. (2021). Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy. Journal of the Endocrine Society, 5(4), bvab019. https://doi.org/10.1210/jendso/bvab019
Cook, Keziah, et al. "Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy." Journal of the Endocrine Society vol. 5,4 (2021): bvab019. doi: https://doi.org/10.1210/jendso/bvab019
Cook K, Adamski K, Gomes A, Tuttle E, Kalden H, Cochran E, Brown RJ. Effects of Metreleptin on Patient Outcomes and Quality of Life in Generalized and Partial Lipodystrophy. J Endocr Soc. 2021 Feb 16;5(4):bvab019. doi: 10.1210/jendso/bvab019. eCollection 2021 Apr 01. PMID: 33817539; PMCID: PMC7993583.
Copy Download .nbib Format: NLM
Delegation of medication administration from registered nurses to non-registered support workers in community care settings: A systematic review with critical interpretive synthesis.

International journal of nursing studies

Shore CB, Maben J, Mold F, Winkley K, Cook A, Stenner K.
PMID: 34896760
Int J Nurs Stud. 2021 Oct 29;126:104121. doi: 10.1016/j.ijnurstu.2021.104121. Epub 2021 Oct 29.

INTRODUCTION: Healthcare workforces are currently facing multiple challenges, including aging populations; increasing prevalence of long-term conditions; and shortfall of registered nurses. Employing non-registered support workers is common across many countries to expand service capacity of nursing teams. One task...

Cite
Shore CB, Maben J, Mold F, et al. Delegation of medication administration from registered nurses to non-registered support workers in community care settings: A systematic review with critical interpretive synthesis. Int J Nurs Stud. 2021;126:104121doi: 10.1016/j.ijnurstu.2021.104121.
Shore, C. B., Maben, J., Mold, F., Winkley, K., Cook, A., & Stenner, K. (2021). Delegation of medication administration from registered nurses to non-registered support workers in community care settings: A systematic review with critical interpretive synthesis. International journal of nursing studies, 126104121. https://doi.org/10.1016/j.ijnurstu.2021.104121
Shore, Colin B, et al. "Delegation of medication administration from registered nurses to non-registered support workers in community care settings: A systematic review with critical interpretive synthesis." International journal of nursing studies vol. 126 (2021): 104121. doi: https://doi.org/10.1016/j.ijnurstu.2021.104121
Shore CB, Maben J, Mold F, Winkley K, Cook A, Stenner K. Delegation of medication administration from registered nurses to non-registered support workers in community care settings: A systematic review with critical interpretive synthesis. Int J Nurs Stud. 2021 Oct 29;126:104121. doi: 10.1016/j.ijnurstu.2021.104121. Epub 2021 Oct 29. PMID: 34896760.
Copy Download .nbib Format: NLM
Enhancing diversity in the public health research workforce: the research and mentorship program for future HIV vaccine scientists.

Stoff DM, Sopher CJ, Adamson BJ, Andrasik MP, Flood DM, Wakefield SF, Cook RS, Kublin JG, Fuchs JD.
UIID-AD: 2619
2015;105:823-30. doi: 10.2105/ajph.2014.302076.

OBJECTIVES: We developed and evaluated a novel National Institutes of Health-sponsored Research and Mentorship Program for African American and Hispanic medical students embedded within the international, multisite HIV Vaccine Trials Network, and explored its impact on scientific knowledge, acquired...

Cite
Stoff DM, Sopher CJ, Adamson BJ, et al. Enhancing diversity in the public health research workforce: the research and mentorship program for future HIV vaccine scientists. 2015;105:823-30doi: 10.2105/ajph.2014.302076.
Stoff, D. M., Sopher, C. J., Adamson, B. J., Andrasik, M. P., Flood, D. M., Wakefield, S. F., Cook, R. S., Kublin, J. G., & Fuchs, J. D. (2015). Enhancing diversity in the public health research workforce: the research and mentorship program for future HIV vaccine scientists. 105823-30. https://doi.org/10.2105/ajph.2014.302076
Stoff, D M, et al. "Enhancing diversity in the public health research workforce: the research and mentorship program for future HIV vaccine scientists." vol. 105 (2015): 823-30. doi: https://doi.org/10.2105/ajph.2014.302076
Stoff DM, Sopher CJ, Adamson BJ, Andrasik MP, Flood DM, Wakefield SF, Cook RS, Kublin JG, Fuchs JD. Enhancing diversity in the public health research workforce: the research and mentorship program for future HIV vaccine scientists. 2015;105:823-30. doi: 10.2105/ajph.2014.302076. UIID-AD: 2619.
Copy Download .nbib Format: NLM
Showing 2293 to 2302 of 2302 entries